Exposure of tumor cells to IFNγ is known to induce pro-inflammatory gene signatures that consequently lead to enhanced recognition by cytotoxic T-lymphocytes (28, 61) mediated by the up-regulation of the APPM and HLA surface expression. The gene discussed is IFNG; the disease is neoplasm.